Simon Conroy1, Teresa Dowsing. 1. Geriatric Medicine, Windsor Building, Leicester Royal Infirmary, Leicester LE1 5WW, UK. spc3@le.ac.uk
Abstract
BACKGROUND: This study assessed the role of frailty assessment in the AMU. METHODS: Patients were assessed for frailty and their outcomes ascertained at 90 days. RESULTS: The Canadian Study on Health and Aging Clinical Frailty Scale categorised 29% of patients as moderately-severely frail. Frailty did not differentially identify those likely to be discharged within one day, nor with long stays. Mortality at 90 days was 32%; frailty was associated with the risk of dying, odds ratio 1.4. 21% of patients were readmitted at 30 days, and 33% at 90 days, but frailty was not predictive. DISCUSSION: Moderate-severe frailty in people aged 70+ was common and was predictive of higher mortality, but did not appear to predict admission, length of stay or readmission.
BACKGROUND: This study assessed the role of frailty assessment in the AMU. METHODS:Patients were assessed for frailty and their outcomes ascertained at 90 days. RESULTS: The Canadian Study on Health and Aging Clinical Frailty Scale categorised 29% of patients as moderately-severely frail. Frailty did not differentially identify those likely to be discharged within one day, nor with long stays. Mortality at 90 days was 32%; frailty was associated with the risk of dying, odds ratio 1.4. 21% of patients were readmitted at 30 days, and 33% at 90 days, but frailty was not predictive. DISCUSSION: Moderate-severe frailty in people aged 70+ was common and was predictive of higher mortality, but did not appear to predict admission, length of stay or readmission.
Authors: T Braun; R-J Schulz; M Hoffmann; J Reinke; L Tofaute; C Urner; H Krämer; T Bock; N de Morton; C Grüneberg Journal: Z Gerontol Geriatr Date: 2015-02 Impact factor: 1.281
Authors: Talal A Alfaadhel; Steven D Soroka; Bryce A Kiberd; David Landry; Paige Moorhouse; Karthik K Tennankore Journal: Clin J Am Soc Nephrol Date: 2015-03-04 Impact factor: 8.237
Authors: Samuel Golpanian; Darcy L DiFede; Marietsy V Pujol; Maureen H Lowery; Silvina Levis-Dusseau; Bradley J Goldstein; Ivonne H Schulman; Bangon Longsomboon; Ariel Wolf; Aisha Khan; Alan W Heldman; Pascal J Goldschmidt-Clermont; Joshua M Hare Journal: Oncotarget Date: 2016-03-15